S-1 Combined Cisplatin HIPEC for Palliative Operation Gastric Cancer of Stage IV Limited Peritoneal Metastasis
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the efficacy of S-1 plus cisplatin hyperthermic
intraperitoneal chemotherapy for advanced gastric patients of gastric cytoreductive surgery
(CRS)